As of July 2026, Grantoria lists 47 Drug Policy Reform Grants — 23 open right now, across 16 funding agencies. Award amounts range $10K to $5M. The next application deadline is July 23, 2026. All listings are free, with direct links to the official application.
The Office of Community Oriented Policing Services (COPS) is the component of the U.S. Department of Justice responsible for advancing the practice of community policing and…
🏛 Community Oriented Policing Services📋 CFDA 16.073⏰ Jul 23, 2026💰
up to $4,000,000
The Office of Community Oriented Policing Services (COPS) is the component of the U.S. Department of Justice responsible for advancing the practice of community policing and…
The purpose of this program is to develop and implement a community-wide prevention program of drug overdose deaths by expanding access to FDA-approved opioid overdose reversal…
🏛 Substance Abuse and Mental Health Services Adminis📋 CFDA 93.490⏰ Jul 27, 2026
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award, a product-driven award mechanism, intends to support the translation of promising…
🏛 Defense Health Agency Contracting Activity - DHACA📋 CFDA 12.420⏰ Aug 6, 2026
The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants…
🏛 National Institutes of Health📋 CFDA 93.121⏰ Aug 18, 2026
The National Institute of Neurological Disorders and Stroke, National Institute of Aging, the NIH Helping to End Addiction Long Term (HEAL) initiative, and other participating NIH…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Sep 30, 2026
The National Institute of Neurological Disorders and Stroke, National Institute of Aging, the NIH Helping to End Addiction Long Term (HEAL) initiative, and other participating ICs…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Sep 30, 2026
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on Alzheimer's disease (AD) and AD-related…
🏛 National Institutes of Health📋 CFDA 93.866⏰ Oct 5, 2026
The National Institutes of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects proposing the optimization and translational development of genomic and biologic therapeutic…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Nov 10, 2026
The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or…
🏛 National Institutes of Health📋 CFDA 93.279⏰ Feb 11, 2027
The NIH Blueprint for Neuroscience Research is interested in continuing to support the BluePrint Neurotherapeutics Network for Small Molecules (BPN-SM)- a program designed to help investigators…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Jun 16, 2027
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent…
🏛 National Institutes of Health📋 CFDA 93.350⏰ Jul 2, 2027
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity…
🏛 National Institutes of Health📋 CFDA 93.121⏰ Aug 18, 2027
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Oct 20, 2027💰
up to $750,000
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Oct 20, 2027
Grantoria currently lists 47 drug policy reform grants, of which 23 are open for applications right now. The database is refreshed daily from official federal sources (Grants.gov and SAM.gov).
When is the next deadline?
The next application deadline is July 23, 2026 — about 6 days away. Deadlines vary by program; open any grant to see its exact closing date and application window.
Who is eligible for drug policy reform grants?
Eligibility is set by each funding program, but drug policy reform grants in this category most often support: Public Authority, Nonprofits, City / Municipal Government and County Government. Check each grant's eligibility summary for the exact applicant types and requirements.
How much funding is available?
Award sizes range from $10K to $5M, depending on the program and applicant. Each grant shows its specific funding range where the agency has published one.
Is Grantoria free to use?
Yes — Grantoria is completely free. No account or subscription is required to browse drug policy reform grants, view deadlines and eligibility, or reach the official application.
How do I apply?
Open any grant to see its full profile — eligibility, required documents, deadlines and a direct link to the official application on the funding agency's website. You apply through the federal portal; Grantoria simply helps you find the right opportunity.
About Drug Policy Reform grants
Drug policy reform grants support research, advocacy, and implementation efforts aimed at modernizing substance abuse policies and treatment approaches. The National Institutes of Health and Food and Drug Administration are among the primary funders in this space, with 47 active grants currently available for eligible organizations.
Most awards range from $950,000 to $1.5 million and use competitive application processes. Public and private universities are the typical recipients, along with K12 institutions. Funding covers research, pilot programs, and capacity-building initiatives. No cost-sharing is required. Filter by recipient type and support category to identify opportunities aligned with your organization's goals.
